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In this research,we hypothesized that novel biomechanical parameters are dis-
criminative in patients following acute ST-segment elevation myocardial
infarction (STEMI). To identify these biomechanical biomarkers and bring
computational biomechanics ‘closer to the clinic’, we applied state-of-the-art
multiphysics cardiac modelling combined with advanced machine learning
and multivariate statistical inference to a clinical database of myocardial
infarction. We obtained data from 11 STEMI patients (ClinicalTrials.gov
NCT01717573) and 27 healthy volunteers, and developed personalized math-
ematical models for the left ventricle (LV) using an immersed boundary
method. Subject-specific constitutive parameters were achieved by matching
to clinical measurements. We have shown, for the first time, that compared
with healthy controls, patients with STEMI exhibited increased LV wall
active tension when normalized by systolic blood pressure, which suggests
an increased demand on the contractile reserve of remote functional myocar-
dium. The statistical analysis reveals that the required patient-specific
contractility, normalized active tension and the systolic myofilament kin-
ematics have the strongest explanatory power for identifying the myocardial
function changes post-MI. We further observed a strong correlation between
two biomarkers and the changes in LV ejection fraction at six months from
baseline (the required contractility (r ¼ 2 0.79, p, 0.01) and the systolic
myofilament kinematics (r ¼ 0.70, p ¼ 0.02)). The clinical and prognostic
significance of these biomechanical parameters merits further scrutinization.
1. Background
Acute myocardial infarction (MI) is a common cause of premature morbidity and
mortality. Although early survival post-ST segment elevation MI (STEMI) is
improving [1], the longer term risk of heart failure remains persistently high
[2]. The standard of care for assessing the initial severity of heart injury is left ven-
tricular (LV) systolic function, and in particular, LV ejection fraction (LVEF) [1].
Nonetheless, global measures of LV pump function are simplistic [3,4], as
compared to biomechanical parameters of pump function, such as myocardial
contractility and stiffness.
There is a growing recognition that a computational approach for ventricu-
lar biomechanics, when integrated with clinical imaging, can provide insights
into heart function and dysfunction [5,6]. For example, carefully designed
models have been used to inform various improvement therapies post-MI [7].
Cardiac dynamics are complex multi-physics problems that involve dynamic
blood flow, electrophysiology, nonlinear deformation and interactions among
them [8]. Substantial effort has been devoted to developing computational
models of the heart from simplified representations to more realistic image-
derived cardiac models [8–12]. Among the computational frameworks that have
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sion of the immersed boundarymethod (IB/FE) [13], one of the
recent extensions of the immersed boundary (IB) method, has
also been used by the authors’ group to simulate LV dynamics
with a hyperelastic representation of the fibre-reinforced
myocardium [12,14,15].
One of the challenges for modelling the heart is that the
myocardial constitutive parameters need to be determined
prior to the modelling. Various approaches have been devel-
oped to estimate those parameters by matching the available
clinical measurements (displacement, strain or pressure–
volume curve) [16–20]. For example, Genet et al. [21] developed
an image-based LV model by matching measured strain and
volume data to construct a reference stress map which may be
used in restoring LV stresses back to a normal level. Predict-
ing the systolic stress inside LV wall will further require the
incorporation of myocardial active contraction [8,9,22,23].
However, the biomechanics leading to LV adverse remo-
delling and heart failure remain incompletely understood
[24], and controversy exists [25]. Modelling of diseased hearts
has attracted a wide interest [12,26] in recent years. Using a
Fung-type constitutive law [23], Guccione and colleagues
found that the myofibre stress is increased in the infarct zone,
and the contractility in the border zone is reduced. They
suggested that the changed mechanical environment may
lead to adverse remodelling post-MI [7,16,26,27]. By develop-
ing a biomechanical porcine heart model, Chabiniok et al.
[28] estimated myocardial contractility from in vivo data at
three time points after acute-MI, and found that the contracti-
lity in the remote regions of MI increased 10 days after
acute-MI, followed by a further increase 38 days later. By simu-
lating LV dynamics using a patient-specific clinical data, Gao
et al. [12] reported that required myocardial contractility after
acute-MI was much higher compared with a control heart,
suggesting an increased use of the contractile reserve in the
myocardial remote zone for the patient. Asner et al. [29] esti-
mated peak contractility in a healthy volunteer and two
patients with dilated cardiomyopathy using personalized
mechanical LV models and, again paradoxically, the higher
peak contractilitywas observed in the patients.However,myo-
cardial contractility varied considerably for healthy and
diseased hearts when estimated using computational models.
The reasons for this variability are unclear but may relate to
inter-individual variations, sample size or technical factors.
Biomechanical parameters, such asmyocardial contractility
andmechanical properties, aremore directly linkedwith pump
performance than global measures of systolic function
(i.e. LVEF), and should have greater discriminative value for
heart function and prognosis. However, direct measurements
of these indices are very challenging, if not impossible
in vivo, which limits the use of higher fidelity measures of
pump function in clinic. Furthermore, it is not immediately
obvious which of the biomechanical parameters have more
clinical relevance or prognostic value [30]. The lack of a case-
controlled study of the myocardial mechanical modelling
between the healthy anddiseased LVsmakes it hard to identity
the links between biomechanical characteristics andMI pathol-
ogies. The aim of this work is to study how myocardial
contractility and pump function varies between healthy
subjects and patients with a recent MI. Our questions are:
(1) Does myocardial mechanically function differ in patients
versus controls?(2) If so, what are the differences in the proposed biomecha-
nical parameters?
(3) Can these parameters be used to classify myocardial con-
tractile function and if so, which classification method
is better?
(4) What are the clinical implications of these parameters?
To address these questions, we firstly carried out an
extreme case–control study of LV biomechanical behaviours
using the IB/FE method in a patient group with acute
STEMI and a control group without history of cardiovascular
disease. Secondly, we applied various machine learning and
statistical classification methods to identify the potential bio-
markers which may reflect myocardial function difference,
and then evaluated their performance. Finally, we analysed
potential associations between the proposed biomechanical
biomarkers and the LV function recovery and remodelling
at six months within the patient group.2. Material and methods
2.1. Study design
The study involves an ‘extreme case–control’ approach [31] in
order to enhance the statistical power of the analysis while
using a limited sample size. The specific clinical focus of this
work will be patients who have suffered a large, acute STEMI
that is associated with reperfusion injury (i.e. no-reflow), which
is a major, life-threatening cause of acute LV pump failure
post-MI [32,33]. No-reflow is defined as an acute reduction in
myocardial blood flow despite a patent epicardial coronary
artery, and is independently associated with adverse remodelling
and adverse outcome [34]. Twenty-seven healthy subjects and 11
patients with acute-MI were enrolled in this study. Cardiac mag-
netic resonance (CMR) scans were used to computationally infer
biomechanical parameters that would otherwise not be available
from in vivo measurements.
2.2. Mechanical left ventricle model
2.2.1. Imaging-derived left ventricle model
In-house developed Matlab (Mathworks, Inc., Natick, MA, USA)
code was used to extract the endocardial and epicardial surfaces
at early-diastole when the LV pressure is lowest [21]. Short-axis
slices from the LV base to apex and three long-axis slices were
chosen for manual segmentation, shown in figure 1a. Figure 1b
shows the reconstructed LV geometry. Details of the CMR scans
and LV geometry reconstruction are provided in the electronic
supplementary material.
In the MI group, CMR scans at 2 days after acute-MI were
chosen formodel construction. Short- and long-axis lategadolinium
enhancement (LGE) images were combined with cine images to
define the infarct region, denoted as UMI shown in figure 1c–e.
To avoid abrupt change of material properties from UMI to
functional myocardium, a transition region adjacent to UMI was
defined within a distance of 10mm of the infarct boundary, similar
to previouswork [12]. The reminder of the LVwall was assumed to
be unaffected by the infarction, denoted as Uun, or the remote
region. A Lagrangian field M(X) was introduced to describe the
extent of the infarction throughout the whole LV geometry U as
M is 1 in the infarct region, 0 in the remote region and linearly
decreases fromUMI towardsUun in the transition region (figure 1f ).
In-house developed b-spline deformable registration method
was used to estimate regional circumferential myocardial strain
from four short-axis slices from the basal plane to mid-ventricle;
each slice was divided into six regions according to the AHA
(a) (b)
(c) (d) (f)
1.0
0.8
0.6
0.4
0.2
0
(e)
Figure 1. LV model constructions for one healthy control and one MI patient based on in vivo magnetic resonance imaging data. The healthy LV model: (a) LV wall
segmentation; (b) reconstructed LV geometry. The MI model (c) short-axis LGE imaging, the infarct region is enhanced with micro-vascular obstruction appearing
dark inside the enhanced region; (d ) long-axis LGE imaging; (e) LV wall segmentation; (f ) reconstructed LV geometry, coloured by MI extent (1: 100% MI, 0: healthy
myocardium). (Online version in colour.)
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systole were calculated using corresponding cine images. For
each LV model, the measurements from one scan consisted of
24 regional circumferential strains and the LV cavity volume.
Because it is difficult to acquire myofibre architecture in vivo, a
rule-based myocardial fibre generation method [11] was used
to describe the fibre and sheet orientations of the myocardium.
Myofibre rotates from 2608 to 608 from endocardium to epicar-
dium, and the fibre along the sheet direction rotates from 2458
to 458. Because end-diastolic pressure in MI patients is usually
higher (10–25mmHg) than healthy subjects (5–10mmHg) [36],
a population-based end-diastolic blood pressure of 8mmHg
was assumed for the healthy group, and 16mmHg was assumed
for the MI group as in [12]. The LV systolic blood pressure (SBP)
was approximated by the cuff-measured systolic pressure taken
just before the CMR scans.2.2.2. Myocardial mechanics
The IB/FE method [13,14] is employed to model the ventricular
dynamics at end-diastole and end-systole (details can be found in
the electronic supplementary material). The myocardial stress
tensor (s s) is modelled as the summation of the active (s a)
and passive (s p) stresses, i.e.
s s ¼ s p þ s a: ð2:1Þ
The myofibre stress is
sf ¼ f^  (s s f^), ð2:2Þ
where f^ is the normalized myofibre direction in the current
configuration. s p is the passive response described using an
invariant-based Holzapfel–Ogden Law [37],
W ¼ a
2b
e½bðI132 logðJÞÞ þ
X
i¼f;s
ai
2bi
fe½biðIw4i1Þ2   1g
þ afs
2bfs
fe½bfsðI8fsÞ2   1g, ð2:3Þ
in which a, b, af, bf, as, bs, afs and bfs are eight unknown parameters,
I1 ¼ tr(C), I4f ¼ fT0Cf0 ¼ f  f, I4s ¼ sT0Cs0 ¼ s  s, I8fs ¼ fT0Cs0 ¼ f  s,
f0 and s0 are the initial fibre and sheet directions, and f and s are the
current fibre and sheet directions. C ¼ FTF is the right Cauchy–
Green deformation tensor, in which F is the deformation gradient.
We assume myofibre can only bear load when taut, thus
Iw4i ¼max(I4i,1). From (2.3), we derive
s p ¼ 1
J
@W
@F
FT  bs
J
log (J2) pIþm[ruþ (ru)T], ð2:4Þwhere bs ¼ 1.0  105 Pa is the bulk modulus, p is the Eulerian
pressure, m ¼ 4 cP is the viscosity, u is the Eulerian velocity
and J ¼ det (F). (bs/J )log(J2) is used to enforce the incompressi-
bility of the immersed solid in addition to the system-wide
incompressibility condition r  u ¼ 0 [14].
The active stress is computed as
s a ¼ Taf^ f^, ð2:5Þ
where Ta is the active tension computed from
Ta ¼ Treq C(lf , z), lf ¼ jFf0jjf0j ¼
ffiffiffiffiffi
I4f
p
, ð2:6Þ
where Treq is the active tension generated by the myocardium
when lf ¼ 1, i.e. Treq is the minimum value required to meet
the pumping demand at the time of imaging. If the innate ability
of the myocyte to contract under the maximum activation is
denoted as Tmax, which may be measured through stress CMR,
then the difference between Tmax and Treq reflects the contractility
reserve of the myocardium. C(lf, z) is the effects of myofilament
kinetics described by Niederer et al. [38] as
Cðlf ,zÞ ¼ TaTreq ¼ ð1þ b0ðlf  1ÞÞ
 z
zmax
1þ aP3i¼1 Qi
1P3i¼1 Qi if
P3
i¼1 Qi  0,
1þ ð2þ aÞP3i¼1 Qi
1þP3i¼1 Qi otherwise,
8>><
>>:
ð2:7Þ
where z is the available fraction of actin binding sites that is
dependent on the intracellular calcium transient, zmax is the maxi-
mum fraction of actin binding sites at a given lf, b0 is a constant
and a is a measure of the curvature of the force–velocity
relationship, Qi(i ¼ 1, 2, 3) are calculated from
dQi
dt
¼ Ai
dlf
dt
 aiQi, ð2:8Þ
where Ai and ai are constants. A simple model of intracellular
calcium dynamics [39] is used to trigger the myocardial con-
traction simultaneously. In our simulations, Treq is inversely
estimated to model the patient-specific systolic LV dynamics,
other parameters (b0, a,Ai, ai, etc.) involved in active tension
generation are adopted from Niederer et al. [38]. To evaluate sys-
tolic myofilament kinetics, we also assess the value of C(lf, z) at
end-systole, denoted by Cs.
The differences of the passive and active myocardial responses
in the remote, transition and the infarct regions are modelled
by changing the strain energy function and active stress [12,26].
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Figure 2. Optimization of Treq in a healthy heart. (a) Finding optimal Treq by
minimizing objective function (equation (2.12)); (b) strain comparison
between CMR measurements and values from the LV model Treq. The differ-
ence in the strain between the measurements and the model prediction is
0.008+ 0.02. (Online version in colour.)
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increases by 50-fold compared with the remote myocardium
[12,27]. Given the similar biological process leading to a MI scar,
we assume that the MI scar of all patients is 50 times stiffer
WMI ¼ (1þ 49M)W , ð2:9Þ
whereM[ [0, 1] takes 0 in the functional myocardium and 1 in the
MI region, with a linear transition between them. We further
assume the MI tissue does not contract, thus the active tension in
the MI heart is
sa ¼ (1M)Ta f^ f^, ð2:10Þ
note that partial contractility within MI region is not conside-
red, but assuming the whole MI region is non-contractible. In
addition, we adopt the definition used in [21] to define normalized
Ta and sf,
Tnorma ¼
Ta
SBP
and snormf ¼
sf
SBP
: ð2:11Þ
2.2.3. Material parameter identification
Material parameters, including a, b, af, bf, as, bs, afs, bfs and Treq, are
determined so that the simulated LV dynamics are in good agree-
ment with corresponding CMR measurements. Specifically, the
passive myocardial parameters are inversely determined from
in vivo data (LV cavity volume and the regional circumferential
strain) using a multi-step optimization scheme [20]. The active
parameter Treq is determined by matching the measured LV end-
systolic volume and systolic circumferential strain (CS) of the
clinical measurements. All other parameters in the active tension
generation model are kept the same as in [12]. The strains are cal-
culatedwith the reference configuration set at end-diastole. For the
healthy subjects, we first inflate the LV model to the end-diastolic
pressure and estimate the passive parameters, then initiate the
systolic contraction to determine Treq. The objective function is
Objhealhty ¼
PN
i¼1 (1i  1mearsuredi )2
N
þ V  V
measured
Vmeasured
 2
, ð2:12Þ
where 1i,V are the ith regional circumferential strain and LV cavity
volume from the model, and 1mearsuredi , V
measured are correspond-
ing measured data. N is the total number of the control points.
Figure 2a shows the optimization of Treq in a healthy LV model,
and figure 2b is the strain comparison between the CMRmeasure-
ments and values from the model predications using the
optimized Treq, with good agreement.
For the MI subjects, we only determine the parameters in
the remote regions because the MI region is modelled as
non-contractile and 50 times stiffer. The passive parameters are
determined similarly as for the healthy models, but Treq in the
remote region is determined by minimizing the objective function
ObjMI ¼
PNun
i¼1 (1i  1mearsuredi )2
Nun
, ð2:13Þ
in whichNun is the number of segmental remote regions. The aver-
age strain data from the unaffected region in theMI group is 13+3
out of 24 segments.
Further comparisons on LV cavity volume and strains with
in vivo CMR measurements are summarized in electronic
supplementary material, table S1.
2.3. Statistical classification methods
The general characteristics that define the difference between a
healthy heart and one that experienced an MI are well known.
However, it is less clear whether the functional myocardium
and its associated biomechanical factors are sufficient to classify
the myocardium from a healthy heart or heart after acute-MI.
Here we will apply seven different techniques from multivariatestatistics and machine learning to assess the potential of myocar-
dial classification given several biomechanical factors and to
identify the methods that yield the highest prediction accuracy.
Our portfolio of methods includes univariate logistic
regression, multivariate logistic regression with several pre-
dictors and the k-nearest neighbours classifier (KNN).
Furthermore, linear discriminant analysis (LDA) will be applied,
as well as sparse logistic regression with L1 regularization
(Lasso). We will evaluate two tree-based methods that exploit
the change of entropy in the data, as defined in electronic
supplementary material, eqn. (S13). This includes decision trees
trained with the C5.0 algorithm, and random forests based on
bagging with feature sub-selection. Finally, we will apply a
non-parametric Bayesian approach with Gaussian processes
and automatic relevance determination (GP-ARD). All these
methods are described in more detail in electronic supplementary
material, §S0.5.
Another important topic is the identification of relevant
factors that exhibit the greatest influence on the classification out-
come. In this study, we attempt to find those biomechanical
factors that possess the strongest explanatory power for the
differentiation of myocardial contractile function from a healthy
heart or a heart with acute-MI. Several of the previously men-
tioned methods provide a measure of factor importance,
including the Lasso, Decision-Trees, Random Forests and
GP-ARD. We will combine the importance measure of these
methods into a single-ranked relevance score to identify the bio-
mechanical factors with the highest explanatory power. The
results for both studies are presented in §§3.4 and 3.5.2.3.1. Method evaluation
We assess the accuracy of correctly predicting myocardial
contractile function from either a healthy or MI heart in
Table 1. Basic characteristics of healthy controls and MI patients. p-Value is from Student’s t-test. CS, systolic circumferential strain; GLS, global longitudinal
strain.
characteristics patients healthy controls p-value
age (year) 57.2+ 10 44.5+ 15.4 0.02
sex (male : female) 9 : 2 16 : 11
systolic blood pressure (mmHg) 118.6+ 16.4 144.6+ 31.2 0.01
diastolic blood pressure (mmHg) 73+ 14 83+ 15 0.09
LV EF (%) 43+ 6 57+ 5 0
LV EDV (ml) 145.5+ 28 127+ 21 0.02
LV ESV (ml) 83+ 21 55+ 14 0
GLS (%) 211.5+ 3.9 221.4+ 4.1 0
CS (%) 20.16+ 0.01 20.18+ 0.02 0.005
infarct size (% LV volume) 39+ 6.0 —
microvascular obstruction (% LV mass) 10.6+ 5 —
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(FP) and false negative (FN) counts. Positive labels refer to MI
heart; negative labels refer to healthy heart. Hence, a true positive
is the correct identification of an MI heart, a true negative is the
correct identification of a healthy heart, a false positive is the mis-
classification of a healthy heart as an MI heart and a false negative
is the misclassification of an MI heart as a healthy heart. These
counts are obtained out of sample with leave-one-out-cross
validation (LOOCV). With LOOCV, a method predicts the
class for one observation i [ f1, . . ., ng at a time based on the
training set of the remaining (n 2 1) observations, where n is
the total number of observations in the labelled dataset. From
the TP, TN, FP and FN counts, we compute the sensitivity,1
specificity2 and the total misclassification error3 to assess
the classification accuracy of a method.
We plot, for all methods included in our study, the sensiti-
vity against the complementary specificity (i.e. 1 minus the
specificity). The results will be shown later in figure 10. The
convex hull of theses scores presents the receiver operating
characteristic (ROC) curve of the ensemble of classifiers we
have trained.4 By numerical integration, we obtain the area
under the ROC curve (AUROC) as an overall indication of
the classification performance. An AUROC value of 0.5 indi-
cates random expectation, whereas the maximum value of 1
gives perfect predictive accuracy.
For the non-parametric Bayesian approach, the regularization
parameters are optimized by maximizing the marginal likelihood
of the training data. For the non-Bayesian approaches, the regular-
ization parameters are obtained based on LOOCV. It is important
to note that the out-of-sample data used for evaluating the
classification performance must not be used for tuning regulariz-
ation parameters, to avoid an overoptimistic bias. We, therefore,
need two nested LOOCV schemes, one for regularization
parameter tuning, the other for method evaluation. This is
best illustrated with an example. Considering four data points
f1, 2, 3, 4g. For method evaluation, we use an outer LOOCV
scheme as follows: training on f1, 2, 3g, evaluating on f4g; training
on f1, 2, 4g, evaluating on f3g; training on f1, 3, 4g, evaluating
on f2g; training on f2, 3, 4g, evaluating on f1g. For each training
set, we use an inner LOOCV scheme for regularization parameter
tuning. So for the first fold, f1, 2, 3g, we have: training on f1, 2g,
regularization parameter tuning on f3g; training on f1, 3g, regular-
ization parameter tuning on f2g; and training on f2, 3g,
regularization parameter tuning on f1g.3. Results
3.1. Characteristics of subjects
The CMR findings of the MI group and the healthy group are
summarized in table 1. Distributions of age, end-diastolic
volume (EDV), SBP, LVEF and CS are shown in figure 3.
3.2. Left ventricle mechanics
Figure 4 shows examples of the mechanical modelling of LV
dynamics in a healthy subject and a MI patient. Figure 4a,b is
the simulated LV geometries from the healthy control at end-
diastole and end-systole, superimposed on CMR cine images,
and figure 4c,d is from the MI model. Figure 4e,f is the distri-
butions of systolic active tension Ta and myofibre stress sf in
the healthy subject. Since there is no active contraction in the
MI region, the MI region is over-stretched to bear the systolic
pressure, as shown in figure 4k, in which the myofibre strain is
positive (inblue), and the remotemyocardiumregion is shorten-
ing. The distribution ofmyofibre stress sf ismore homogeneous
in the healthyheart comparedwith theMIheart. Similar pattern
is shown in myofibre strain in figure 4i,k. Figure 4j,l shows the
LV twist relative to the LV base, which linearly increases
towards the apex with a maximum apical rotation of around
148 in the healthy model, but only 48 in the MI model.
Table 2 summarizes the average passive parameters of all
the healthy and MI subjects. Figure 5 plots the average passive
stiffness along the myofibre direction, and shows that the pas-
sive myofibre stiffness in the remote regions of the MI patients
is much stiffer than the controls. This is a consequence of the
myocardium adaptivity to MI and simply modelled using a
higher end-diastolic pressure for the MI patients [36]. This
increase corresponds with a stiffer myocardium for a given
deformation [20].
The average Treq in the healthy group is 157+25 kPa, and
156+27 kPa in theMI group, as shown in figure 6a. No signifi-
cantdifference is found inTreq for the twogroups. Similar results
are found for Ta and systolic myofibre stress sf as shown in
figure 6b,c. However, the average Tnorma in the healthy group
is much lower than the MI group (0.45+0.06 kPammHg21—
healthy versus 0.55+0.07 kPammHg21—MI, p, 0.01).
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21—
health versus 0.47+0.09 kPammHg21— MI, p, 0.01). The
systolic myofilament kinetics Cs is 0.42+0.04 in healthy
group, which is slightly lower than 0.44+0.13, p ¼ 0.50 in
the MI group. Figure 7 shows the distributions of Tnorma ,
snormf and C
s. Interestingly, even with a wider range of SBP,
the standard deviations of Tnorma , s
norm
f and C
s in the healthy
group are much smaller compared with the MI group.
From the biomechanical models, we choose Ta, Treq, T
norm
a ,
sf and C
s as potential biomarkers for myocardial contractile
function, but not passive stiffness and diastolic stress because
of uncertainties in assumed end-diastolic pressure. A linear
correlation analysis is further carried out to decide which fea-
tures should be included in statistical feature classification and
summarized in the electronic supplementary material. The cri-
teria are that if two features are highly correlated in both the
healthy and the MI groups, and further related to other fea-
tures and CMR measurements in a similar way, then the
more reliable feature will be selected. For example, Ta and sf
are generally inter-related through the myocardial mechanical
model, see equation (2.1), as is also confirmed by the linear cor-
relation analysis. Furthermore, Ta and sf relate to other features
in a similar way, but part of sf is dependent on the passive
stress (equations (2.1) and (2.2)). Therefore, Ta is selected.Although Cs is correlated to Ta in both groups, they relate to
CMR measurements in different ways; therefore, Cs is
included. Similarly, for Treq and T
norm
a . We also include
EDV and SBP from CMR measurements because both are
inputs for modelling the LV contraction, but not EF, systolic
strain and end-systolic volume, which can be reproduced
from the LV models. In summary, the selected features for
classification of myocardial contractile function between the
healthy group and the STEMI group are: SBP, EDV, Ta,
Tnorma , Treq and C
s.
3.3. Datasets
Three datasets, based on the analysis in §3.2, are evaluated,
which differ in the selected biomechanical factors that serve
as predictors: the first dataset D1 includes the factors Treq,
Ta, SBP, EDV, C
s and Tnorma . The second set denoted with
D2 lacks the ratios. The third set D3 includes Ta, EDV, C
s
and Tnorma but not SBP and Treq, whose effects are included
in Tnorma and C
s, respectively.
3.4. Factor importance
In this section, we discuss the relevance or importance of the
various explanatory variables included in the three datasets.
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Figure 4. Examples of mechanical modelling of LV dynamics from a healthy control and a MI patient. (a) Deformed LV geometry at end-diastole and end-systole
(b) from a healthy volunteer; (c) deformed LV geometry at end-diastole and at end-systole (d ) from a MI patient; (e) distributions of systolic active tension and
(f ) myofibre stress from the healthy volunteer; (g) distributions of systolic active tension and (h) myofibre stress from the MI patient; (i) systolic myofibre strain
distribution and ( j ) twist degree from LV base to apex from the healthy volunteer; (k) systolic myofibre strain distribution and (l ) twist degree from LV base to apex
from the MI patient. (Online version in colour.)
Table 2. Average passive material parameters.
a (kPa) b af (kPa) bf as (kPa) bs afs (kPa) bfs
controls 0.18+ 0.1 2.6+ 0.8 3.34+ 0.94 2.73+ 1.06 0.69+ 0.26 1.11+ 0.40 0.31+ 0.18 2.58+ 0.71
MI subjects 0.09+ 0.04 4.05+ 1.6 6.8+ 3.25 5.53+ 1.84 1.5+ 0.66 1.93+ 0.78 0.16+ 0.07 4.22+ 1.7
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is given by the absolute value of the average regression
coefficient associated with that variable. For GP-ARD,
the importance measure is expressed as the inverted and
normalized length scale associated with the corresponding
explanatory variable. The larger the length scale, the larger
the change of the corresponding variable has to be to have
any effect on the output. For the extreme case of an infinite
length scale, any finite change in the corresponding explana-
tory variable has no effect on the output, and this variable
has therefore effectively been switched off. The Decision-
Tree provides (figure 8) the usage metric to quantify the
importance of an explanatory variable, showing the percen-
tage of times the respective explanatory variable has been
selected by the C5.0 algorithm to build the tree. For the
Random Forest, the importance measure is the mean decrease
in classification accuracy incurred when excluding an
explanatory variable from the training set.
For each of these methods, we rank the explanatory vari-
ables, and combine the results in an accumulative rank score,
which serves as an indicator for the overall factor relevance.These accumulative scores are shown in figure 9, which
shows the cumulative ranks based on the importance from 0
to ( p2 1), where ( p2 1) is the highest rank. The height of
the bars in figure 9 provides a global indication of the associ-
ation of the respective input variables with the output, or to
paraphrase this: the higher the bar in figure 9, the greater is
the relevance of the corresponding factor for predicting the
classification outcome. It is seen that, overall, the two ratios
Cs and Tnorma have the strongest explanatory power in predict-
ingmyocardial contractile function from healthy orMI hearts.5
However, our classification results, discussed below and suc-
cinctly summarized in figure 10, show that the best
performance is achieved when all the available factors are
included in the set of predictors. Hence, no individual
factor is completely irrelevant.3.5. Classification performance
We have applied the classification methods mentioned in §2.3,
and described in more detail in electronic supplementary
material, §S0.5, to the three datasets described in §3.3. The
40
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Figure 5. Average passive stiffness along myofibres in healthy controls and
MI patients. Error bar is the standard deviation. (Online version in colour.)
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sensitivity, specificity and overall misclassification error. The
overall method ranking is shown in the last row of table 4
and is based on the sumofmisclassification errors over all data-
sets. Given these scores, KNN and GP-ARD are the preferred
methods. Figure 10 shows the sensitivity–specificity score
pairs obtained with the different statistical/machine learning
methods, for the three datasets described in §3.3. As described
in §2.3.1, the convex hull of these scores, indicated by a dashed
line, defines the ROC curve that connects the best methods.
Methods that lie below this ROC curve are suboptimal. It is
seen that none of the statistical/machine learning methods is
optimal for all three datasets. However, KNN and GP-ARD
are optimal for two datasets, and close to optimal for the
third. In agreement with table 4, they can thus be regarded
as the best methods overall. Note, in particular, that the uni-
variate methods either clearly fall below the convex hull, or
give the trivial score pair of both sensitivity and complemen-
tary specificity equal to zero (which is obtained when
patients are always classified as healthy). This finding confirms
the need for multivariate methods. As discussed in §2.3.1,
the ROC curve corresponds to a combination of the best-
performing methods, and the area under the ROC curve
(AUROC) is a measure of the overall classification perform-
ance. Our study indicates that the AUROC score depends on
the dataset and varies between 0.77 and 0.9. This is consider-
ably better than random expectation (0.5) and, in the latter
case, close to optimal prediction (1.0).
3.6. Associations between biomechanical factors at
baseline and left ventricle function atsix-month
follow-up
Section 3.4 shows that Tnorma and C
s are the strongest explana-
tory factors in predicting myocardial contractile function
between healthy subjects and MI patients, followed by Treq.
Therefore, in this section, the association between Tnorma , C
s,
Treq and LV pump function recovery at six months is further
analysed. Figure 12 shows the relationship between LV
pump function recovery at six months and Treq, C
s at baseline
in the MI group. It can be seen that a strong linear relationship
between Treq, C
s at baseline and LVEF changes at six months.
With a lower Treq, the MI patient could have a better LVEF
recovery after six months. Thus, we hypothesize that foracute-MI patients with a similar calcium handling dynamics,
a lower Treq suggests a potential to further increase the contrac-
tile function, without going into de-compensated states,
compared with cases when the myocardial contractility
already reaches themaximum. Since themaximummyocardial
contractility is limited, less usage of the contractile reserve will
give the heart more resilience in the longer term. We also
observe that Cs is positively related to LV EF changes at six
months. Since Cs is associated with the myofilament kinetics,
this presumably suggests there aremore binding sites available
at systole for generating the active tension. However, no corre-
lations are found between Ta, T
norm
a , sf, s
norm
f and LV function
at six-month follow-up, which are summarized in table 3.4. Discussion
4.1. The LV mechanical modelling
Themajor determinant of long-term survival after an acute-MI
is the efficiency of LV pump function. Despite decades of
research, the pathophysiology and disease mechanisms of the
failing heart remain incompletely understood, engendering a
knowledge gap for the development of new therapies. It is
believed that novel mathematical tools are required to solve
those fundamental patho-physiological questions. In this
study, we have modelled the LV dynamics at end-diastole
and end-systole in healthy controls and in patients with
recent STEMI. The computational contracting LV models are
based on in vivo CMR data. Using this approach, we inversely
determine the passive parameters and contractility for all the
LV models. We have shown for the first time that, compared
with healthy controls, patients with recent STEMI exhibit
increased active tension, i.e. increased contractility and
increased active tension, when normalized by SBP.
It is challenging to estimate myocardial passive stiffness
inversely, especially with limited measurements in vivo. Our
previous study [20] showed that although the eight constitutive
parameters from the Holzapfel–Ogden Law (equation (2.3))
cannot be uniquely estimated inversely, the mechanical
response alongmyofibre direction for a functional myocardium
can be robustly obtained. One of themain limitations in estimat-
ing the passive myocardial parameters in this study is the
assumed population-based end-diastolic pressure, and the MI
grouphas ahigherend-diastolic pressure (16mmHg) compared
to the healthy control groups (8mmHg). The end-diastolic
pressure is one of the key input in the parameter estimation,
and a higher pressure is associated with a stiffer myocardium.
Without knowing the actual end-diastolic pressure for the MI
and healthy groups, the quantitative change in the myocardial
stiffnessmaybe subject to someuncertainty.However, previous
studies [17] and our own experiments show that the passive
stiffness uncertainty arising from end-diastolic pressure has
few effects on the contractility (Treq) estimation because of the
matched EDV and the strain data.
The patient-dependent myocardial systolic contractility in
our simulations is controlled by the parameter (Treq), all other
parameters of the active tension generation are kept fixed. This
allows us to match measured LV dynamics in end-systole, and
avoid the complexity of determining many parameters in the
electromechanical models from different functional and struc-
tural scales. This approach has been widely applied when
mathematically simulating LV systolic dynamics [12,21,26,27].
The average required myocardial contractility for the control
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the reported value by Genet et al. [21] from five normal
human subjects, the peak contractility reported by Arsner
et al. [29] in one healthy volunteer (139 kPa), and the average
contractility reported by Wang et al. [40] from six healthy
human subjects.
A transition region is defined in MI hearts to avoid abrupt
change of material properties from MI to functional myocar-
dium following our previous study [12]. We remark this doesnot necessarily represent the MI border zone which can also
be modelled with partial contractility as in [41]. We did not
attempt to model the detailed border zone region effects in
this study as we could not extract the border zone and its via-
bility from the CMR images. Thus, we adopted a simplified
approach to only consider two regions in the MI hearts: the
functional myocardium and non-contractile MI region. Future
work to accurately define the border zone and the material
properties within and around the scar based on new imaging
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mathematical models have been developed which can map
the myocardial viability from LGE images that provide partial
contraction inside MI [42].It has been found that myocardial mechanics are depen-
dent on the underlying fibre architecture [11]. However,
because of the difficulties of acquiring detailed subject-
specific fibre architecture in vivo, such fibre structures are
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Figure 10. (a–c) Summary of classification accuracy for different methods and three datasets D1, D2 and D3 (columns). The area under the ROC curve (AUROC) is
calculated from the area under the convex hull (dashed lines) that connects the best performing methods. The specificity and sensitivity score for each method was
estimated with LOOCV. Each of the symbols for the univariate logistic regression (univariate LR) corresponds to one feature used as predictor.
Table 3. Associations between global measures of LV systolic function early post-MI and surrogate outcomes of LV function at six-month follow-up. A p-value
0.05 is taken as statistically significant (in bold).
change in LVEF after six months GLS after six months
baseline coefficient 95% CI p-value coefficient 95% CI p-value
LVEF (%) 20.26 [20.74, 0.41] 0.45 20.43 [20.82, 0.23] 0.19
GLS (%) 20.05 [20.63, 0.57] 0.90 0.73 [0.22, 0.92] 0.01
CS (%) 0.43 [20.23, 0.82 ] 0.19 0.12 [20.52, 0.67] 0.73
Treq (kPa) 20.79 [20.94, 20.37] 0.003 0.27 [20.40, 0.75] 0.43
Ta (kPa) 0.33 [20.33, 0.78] 0.31 20.13 [20.68, 0.51] 0.70
sf (kPa) 0.46 [20.19, 0.83] 0.15 20.14 [20.68, 0.50] 0.68
Tnorma (kPa mmHg
21) 0.24 [20.42, 0.73 ] 0.48 20.08 [20.65, 0.55] 0.82
snormf (kPa mmHg
21) 0.48 [20.17, 0.84] 0.13 20.13 [20.68, 0.51] 0.70
Cs 0.70 [0.16, 0.91] 0.02 20.26 [20.74, 0.41] 0.45
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most models, this study included, employ rule-based fibres
[7,26,42]. To assess the sensitivity of the results due to small
changes of fibre architecture, we further increased the myofi-
bre angle by 10% in a healthy heart, that was, 2668 to 668,
compared with the original myofibre rotation from 2608 to
608. We found that Treq was decreased by 6%, and Ta was
slightly reduced by ( 1.8%).We are aware that our current mechanical model is still
necessarily simplified, in particular, with one chamber and
the LV dynamics are simulated at two time points only (end-
diastole and end-systole). Moreover, a simplified intracellular
transient is used to trigger active contraction simultaneously,
due to lack of parametrization in cellular level, Cs may only
represent an ‘apparent’ myofilament kinetics under same
intracellular calcium dynamics.
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0.1
0.1
0.
1
0.
1
0.1
0.2
0.2
0.
2
0.
2
0.2
0.3
0.3
0.3
0.3
0.3
0.4
0.4
0.4
0.4
0.4
0.5
0.5
0.6
0.6
0.6
0.6
0.6
0.6
0.6
0.7
0.7
0.7
0.7
0.7
0.7
0.8
0.8
0.8
0.8
0.8
0.9
0.9
0.9
0.5
0.5
0.5
–1 0 1 2 3 4
CS
–1.5
–1.0
–0.5
0
0.5
1.0
1.5
(a) (b)
T r
eq
GP ARD: posterior probabilities
0.
1
0.1
0.
2
0.2
0.
2
0.
3
0.3
0.
3
0.4
0.4
0.4
0.5
0.6
0.6
0.60.7
0.7
0.70.
8
0.8
0.8
0.8
0.9
0.9
0.5
0.5
–1 0 1 2 3 4
Cs
–1.5
–1.0
–0.5
0
0.5
1.0
1.5
2.0
2.5
T
an
o
rm
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Table 4. Overview of misclassification error rate and sensitivity/specificity measures for different methods and datasets. A low error, and high sensitivity/
specificity indicate better prediction accuracy. The corresponding ROC plot is shown in figure 10. For the univariate logistic regression (Univariate LR), only the
prediction with the lowest error is shown. The best scores for each dataset are shown in bold. The last row indicates the method ranks based on the sum of
errors from each dataset. The lowest ranks correspond to methods with the highest classification accuracy.
Lasso Univariate LR Multivariate LR KNN LDA Decision-Tree Random-Forest GP-ARD
D1 error 0.11 0.24 0.079 0.11 0.11 0.18 0.21 0.13
specificity 0.96 0.85 0.96 1 0.96 0.93 0.96 0.93
sensitivity 0.73 0.55 0.82 0.64 0.73 0.55 0.36 0.73
D2 error 0.24 0.26 0.21 0.11 0.26 0.18 0.29 0.11
specificity 0.89 0.89 0.89 1 0.89 0.96 0.85 0.96
sensitivity 0.45 0.36 0.55 0.64 0.36 0.45 0.36 0.73
D3 error 0.21 0.24 0.21 0.18 0.21 0.21 0.18 0.18
specificity 0.93 0.85 0.89 0.89 0.93 0.93 0.93 0.89
sensitivity 0.45 0.55 0.55 0.64 0.45 0.45 0.55 0.64
rank
(error sum)
4
(0.56)
8
(0.74)
3
(0.49)
1
(0.4)
6
(0.58)
5
(0.57)
7
(0.68)
2
(0.42)
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lation in terms of real time prediction, and our combined
mechanical, statistical and MRI study already show promis-
ing value in evaluating myocardial functions between the
healthy subjects and MI patients.4.2. Statistical classification
Our ultimate aim is to build a classifier (case versus control)
based on in vivo imaging data described in the electronic
supplementary material. However, working directly on the
images, e.g. representing them as grey-level pixel vectors
and building a classifier in this high-dimensional space, leads
to the well-known curse-of-dimensionality problem [43].
Standardapproaches, therefore, carryout adimension reduction
first. In the simplest case, this can be done with principal com-
ponent analysis. More advanced methods aim to improvedimension reduction by identifying low dimensional submani-
folds of the high-dimensional configuration space that contain
the relevant information related to the classification problem
at hand. Our present research can be seen as an extension of
previous work whereby the low-dimensional configuration
space is directly spanned by the parameters of an explicit
biomechanical model. This is model-based rather than purely
data-driven dimension reduction, with the advantage that
for a reliable and accurate model, the reduced configuration
space is a priori highly likely to contain physiologically
relevant information.
We have worked in the biomechanical parameter space
with a variety of methodological tools. We have started with
a simple univariate analysis, followed by a multivariate
approach, wherewe have used the latter to evaluate the relative
explanatory relevance of the various biomechanical parameters
with respect to the classification task and to compare the
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classification methods over the univariate approach.
In the univariate approach, by simply comparing the
different biomechanical parameters, several parameters are
identified for classifying myocardial contractile function from
either a healthy heart or a MI heart, including SBP, EDV,
Tnorma , Treq, C
s and Ta. However, the simplified comparison,
such as using the S student t-test, has its limitations, as
shown in figure 7. OnlyTnorma is found to be significantly differ-
ent between the control group and the MI group. In the second
part of the study, we have shown that multivariate statistical
methods provide more powerful tools for classifying the
difference in myocardial contractile function after acute-MI.
In the second part, we have used several machine learning
and computational statisticalmethods to identify the biomecha-
nical factors that possess the strongest explanatory power for
predicting the changes in myocardial contractile function after
acute MI. Our study has revealed that Cs and Tnorma are the
most relevant factors for this classification task, but that no
individual factor is completely irrelevant. For details, see §3.4.
In the next evaluation step, we have predicted myocardial
contractile function between healthy and MI hearts based on
the previously mentioned biomechanical factors with eight
different methods. Figure 10 and table 4 summarize the predic-
tion performance and the overall best possible performance
given all methods. The univariate approach (Univariate LR)
shows the poorest performance, as discussed in §3.5. Among
the multivariate approaches, KNN and GP-ARD show the
best performance (see §3.5 for more details). GP-ARD allows
us to visualize the posterior probability of MI heart as a func-
tion of the two most important factors; this is shown in
figure 11. The plots in this figure illustrate three things. Firstly,
it requires more than one factor or variable to separate the data
into the two classes. This confirms that a univariate approach is
too restrictive, and that a multivariate approach is needed.
Secondly, the separation boundaries are nonlinear. This
explains why the nonlinear methods, KNN and GP-ARD,
show in general a better performance than their linearcounterparts. Thirdly, the folding of the decision boundary is
very narrow. This explains why the best performance with
KNN is achieved with low values of k.
The overall predictive accuracy given all methods can be
summarized with the AUROC score, which is displayed in
figure 10 for each dataset. As it was previously mentioned,
the overall accuracy improves from 0.86 to 0.9 when Cs and
Tnorma are added to the single factors present in dataset D2.
This AUROC value is considerably larger than random
expectation (0.5) and quite close to perfect prediction (1.0).
To rule out that Cs and Tnorma are for themselves sufficient
predictors for the two heart conditions, we excluded Treq
and SBP and found a significant drop in the AUROC value
to 0.77. This implies a synergy, i.e. interaction effect, of the
involved factors. Hence all the available factors present in
D1 are important myocardial contractile function indicators
that should be used in conjunction to differentiate myocardial
contractile function between healthy and MI hearts.
4.3. Clinical implication
The estimated overall myocardial contractility Treq, T
norm
a and
Cs, as suggested in the classification part, might potentially be
biomarkers for risk stratification of MI patients. However,
since our study has a limited sample size with selected
patients, it is not immediately obvious which, if any, of the bio-
mechanical parameters might have clinical prognostic value,
and further research is warranted. The linear correlation analy-
sis (figure 12) might suggest that Treq and C
s could be
potentially used to identify MI patients who may have better
recovery by using inotropic treatment if Treq is in a normal
range or by reducing Treq if it is high.
Future prospective studies should investigate the mechan-
ism of how Treq, C
s and Tnorma link with myocardial contractile
function throughdifferent pathways. The effects of novel thera-
pies on these biomechanical parameters should also be
assessed. Finally, future studies should evaluate whether
these to determine the incremental prognostic value of Treq,
Cs and Tnorma to identify individual patients at high risk of
heart failure post-MI, over and above standard prognosticmar-
kers such as natriuretic peptides. The strategy to achieve such
improvements could involve identification of high-risk patient
subsets, identification of subsets of patients with viable myo-
cardium who might be expected to respond to therapy, and
implementation of more intensive therapy. Future heart failure
management and therapiesmay be targeted to restore the over-
all LV contractile reserve according to the level of myocardial
contractility and its reserve, such as either downregulating of
adrenergic signalling to reduce contractility or using inotropic
treatments to enhance it.5. Conclusion
Using combined personalized computational cardiac biome-
chanical modelling and statistics analysis, we have studied
systolic LV dynamics for one patient group consisting of 11
acute STEMI patients with no-reflow and a group of healthy
control subjects, based on CMR imaging. The passive response
and active contractile properties ofmyocardiumare determined
by matching the simulated LV dynamics (volume and circum-
ferential segmental strains) to the CMR measurements. We
find that, compared with healthy controls, patients with
STEMI exhibit increased LV wall active tension when
rsif.royalsocietypublishing.org
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 on July 27, 2017http://rsif.royalsocietypublishing.org/Downloaded from normalized by SBP. This suggests that the functional myocar-
dium in the patients are overcompensating in order to
preserve the stroke volume. Different machine learning and
multivariate statistical analysis methods are applied to identify
the biomechanical factors that possess the explanatory power in
terms of the changed myocardial contractile function after
STEMI. The individual required contractility (Treq), normalized
active tension Tnorma and the systolicmyofilament kineticsC
s are
found to have the strongest explanatory power, and the statisti-
cal method KNN has shown the best performance for the
classification of myocardial contractile function, followed by
GP-ARD. We further observe strong correlations between the
biomarkers (Treq, C
s) and the changed LVEF at six months
from baseline (r ¼ 2 0.79, p, 0.01, r ¼ 0.70, p ¼ 0.02). We con-
clude that the patient-specific contractility Treq, the normalized
active tension Tnorma , and the myofilament kinetics C
s all have
potential clinical values for prognostication on LV contractile
status post-MI, their significance merits further study in larger
and unselected patient cohorts.
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false positive rate, is the proportion of correctly classified healthy
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4Consider two classifiers, with true positive rates TRP1 and TRP2, and
with true negative rates TNR1 and TNR2. Now define a family of new
classifiers as follows: with probability l[ [0, 1], they use classifier 1,
and with probability (12 l), they uses classifier 2. The expected
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